• 1
    International Agency for Research on Cancer Working Group on the Evaluation of Cancer-Preventive Agents (2002) Weight Control and Physical Activity (IARC Handbooks of Cancer Prevention, Vol. 6). IARC: Lyon, France.
  • 2
    McTiernan, A., Ulrich, C., Slate, S., Potter, J. (1998) Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control. 9: 487509.
  • 3
    Endogenous Hormones and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 94: 606616.
  • 4
    Hankinson, S., Willett, W., Michaud, D., et al (1999) Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 91: 629634.
  • 5
    Tworoger, S., Eliassen, A., Rosner, B., Sluss, P., Hankinson, S. (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res. 64: 68146819.
  • 6
    Manjer, J., Johansson, R., Berglund, G., et al (2003) Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control. 14: 599607.
  • 7
    Lukanova, A., Lundin, E., Micheli, A., et al (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 108: 425432.
  • 8
    Judd, HL, Shamonki, IM, Frumar, AM, Lagasse, LD (1982) Origin of serum estradiol in postmenopausal women. Obstet Gynecol. 59: 680686.
  • 9
    Meldrum, D., Davidson, D., Tateryn, I., Judd, H. (1981) Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol. 57: 624628.
  • 10
    Siiteri, PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr. 45 (Suppl 1): 277282.
  • 11
    Siiteri, PK, Murai, JT, Hammond, GL, Nisker, JA, Raymoure, WJ, Kuhn, RW (1982) The serum transport of steroid hormones. Recent Prog Horm Res. 38: 457510.
  • 12
    Bezemer, I., Rinaldi, S., Dossus, L., et al (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 16: 561572.
  • 13
    Boyapati, S., Shu, X., Gao, Y., et al (2004) Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women. Cancer Causes Control. 15: 305311.
  • 14
    Cauley, JA, Gutai, JP, Kuller, LH, LeDonne, D., Powell, JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 129: 11201131.
  • 15
    Hankinson, SE, Willett, WC, Manson, JE, et al (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 87: 12971302.
  • 16
    McTiernan, A., Rajan, KB, Tworoger, SS, et al (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol. 21: 19611966.
  • 17
    Verkasalo, PK, Thomas, HV, Appleby, PN, Davey, GK, Key, TJ (2001) Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 12: 4759.
  • 18
    Ritenbaugh, C., Patterson, R., Chlebowski, R., et al (2003) The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 13: S87S97.
  • 19
    Patterson, RE, Kristal, AR, Tinker, LF, Carter, RA, Bolton, MP, Agurs-Collins, T. (1999) Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 9: 178187.
  • 20
    Langer, R., White, E., Lewis, C., Kotchen, J., Hendrix, S., Trevisan, M. (2003) The Women's Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 13: S107S121.
  • 21
    McTiernan, A., Kooperberg, C., White, E., et al (2003) Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA. 290: 13311336.
  • 22
    Vermeulen, A., Verdonck, L., Kaufman, JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 84: 36663672.
  • 23
    Rinaldi, S., Geay, A., Dechaud, H., et al (2002) Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev. 11: 10651071.
  • 24
    Hays, J., Hunt, J., Hubbell, F., et al (2003) The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 13 (Suppl 9): S18S77.
  • 25
    McTernan, P., Anderson, L., Anwar, A., et al (2002) Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J Clin Endocrinol Metab. 87: 13271336.
  • 26
    McTiernan, A., Tworoger, SS, Ulrich, CM, et al (2004) Effect of exercise on serum estrogen in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 64: 29232928.
  • 27
    Kwa, H., Cleton, F., Bulbrook, R., Wang, D., Hayward, J. (1981) Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Int J Cancer. 28: 3134.
  • 28
    Unzer, S., dos Santos, J., Moreira, A., Vilanova, M., de Sa, M. (1995) Alternatives in plasma gonadotropin and sex steroid levels in obese ovulatory and chronically anovulatory women. J Reprod Med. 40: 516520.
  • 29
    Flint, D., Binart, N., Kopchick, J., Kelly, P. (2003) Effects of growth hormone and prolactin on adipose tissue development and function: review. Pituitary. 6: 97102.
  • 30
    Ling, C., Svensson, L., Oden, B., et al (2003) Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J Clin Endocrinol Metab. 88: 18041808.
  • 31
    Baker, E., Mathur, R., Kirk, R., Landgrebe, S., Moody, L., Williamson, H. (1982) Plasma gonadotropins, prolactin, and steroid hormone concentrations in female runners immediately after a long-distance run. Fertil Steril. 38: 3841.
  • 32
    Boyden, T., Pamenter, R., Grosso, D., Stanforth, P., Rotkis, T., Wilmore, J. (1982) Prolactin responses, menstrual cycles, and body composition of women runners. J Clin Endocrinol Metab. 54: 711714.
  • 33
    Shangold, M., Gatz, M., Thysen, B. (1981) Acute effects of exercise on plasma concentrations of prolactin and testosterone in recreational women runners. Fertil Steril. 35: 699702.
  • 34
    Kraemer, R., Blair, M., McCaferty, R., Castracane, V. (1993) Running-induced alterations in growth hormone, prolactin, triiodothyronine, and thyroxine concentrations in trained and untrained men and women. Res Q Exerc Sport. 64: 6974.
  • 35
    Wang, CY, Anderson, G., Prentice, RL (1999) Estimation of the correlation between nutrient intake measures under restricted sampling. Biometrics. 55: 711717.
  • 36
    Tworoger, S., Chubak, J., Aiello, E., et al (2004) The effect of CYP19and COMT polymorphisms on exercise-induced fat loss inpostmenopausal women. Obes Res. 12: 972981.
  • 37
    Bingham, S., Luben, R., Welch, A., Wareham, N., Khaw, K., Day, N. (2003) Are imprecise methods obscuring a relation between fat and breast cancer? Lancet. 362: 212214.
  • 38
    Lichtman, SW, Pisarska, K., Berman, ER, et al (1992) Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med. 327: 18931898.
  • 39
    Hebert, J., Patterson, R., Gorfine, M., Ebbeling, C., St Jeor, S., Chlebowski, R. (2003) Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Ann Epidemiol. 13: 629637.
  • 40
    Toniolo, P., Koenig, K., Pasternack, B., et al (1994) Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev. 3: 4750.
  • 41
    McTiernan, A., Tworoger, S., Rajan, B., et al (2004) Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 13: 17.